Ann: Q&A on the merger of QBL MCL and Medcan, page-333

Without accurate information I have no means of determining a value.
I do think the cannabis industry is primed for growth and MCL has the business structure to take full advantage of that BUT the tendency for QBL to use grandiose verbiage or over inflate claims made in ANN's gives credence to them having over inflated their own idea of the value of 45% of MCL .
A lower estimation IMO would have had a much different reaction by the market and meant success all round.
I initially invested and hoped for preference in the IPO of MCL.. with an IPO comes a full prospectus .. seeing in detail the scope of MCL in part covered in this latest ANN but the numbers are missing. Hopefully as you say the quarterly and any hemp info released will address this.